Optimizing Chemotherapy Protocol for Diverse Patient Populations
DOI:
https://doi.org/10.56570/jimgs.v2i2.127Keywords:
Chemotherapy optimization, Diverse patient populations, Multidisciplinary approach, Pharmacogenetic biomarkers, Toxicity profilesAbstract
Chemotherapy optimization for diverse patient populations is a complex and challenging task that requires a multidisciplinary and individualized approach. Oncology professionals need to be aware of the factors that can affect the response and toxicity of chemotherapy drugs in different patient populations and apply the best available evidence and practices to tailor chemotherapy regimens accordingly. Further research is needed to identify more pharmacogenetic biomarkers, develop more accurate dosing formulas, evaluate more drug interactions, and compare more toxicity profiles for chemotherapy optimization for diverse patient populations.References
Gasparini G, Buttitta F, D'Andrea MR, Tumolo S, Buonadonna A, Pavese I, Cordio S De Tursi M, Mosconi S, Stumbo L, Felicioni L, Marchetti A. Neoplasia. 2014 Sep;16(9):751-6. doi: 10.1016/j.neo.2014.08.002. PMID: 25246275; PMCID: PMC4234870.
Optimizing a photoallodepletion protocol for adoptive immunotherapy after haploidentical SCT. Bone Marrow Transplant.Perruccio K, Topini F, Tosti A, Carotti A, Burchielli E, Ruggeri L, Mancusi A, Urbani E, Aversa F, Martelli MF, Velardi A. 2012 Sep;47(9):1196-200. doi: 10.1038/bmt.2011.237. Epub 2011 Dec 5. PMID: 22139067.
Medical Oncologists' Perceptions of Financial Incentives in Cancer CareJ Clin Oncol. 2013 Feb 10; 31(5): 530-535. Published online 2012 Dec 26. doi: 10.1200/JCO.2012.43.6063PMCID: PMC3565179PMID: 23269996.
The Role of Primary Care Physicians in Cancer CareJ Gen Intern Med. 2009 Sep; 24(9): 1029-1036. Published online 2009 Jul 14. doi: 10.1007/s11606-009-1058- xPMCID: PMC2726889PMID: 19597893
DeVita VT Jr, Chu E. A history of cancer chemotherapy. Cancer Res. 2008 Nov 1;68(21):8643-53. doi: 10.1158/0008-5472.CAN-07-6611. PMID: 18974103.
